CASP1
Caspase-1
Also known as: CASP1_HUMAN, ICE, IL1BC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29466
- Gene
- CASP1
- Ensembl
- ENSG00000137752
- Chromosome
- 11
- Canonical length
- 404 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. This gene was identified by its ability to proteolytically cleave and activate the inactive precursor of interleukin-1, a cytokine involved in the processes such as inflammation, septic shock, and wound healing. This gene has been shown to induce cell apoptosis and may function in various developmental stages. Studies of a similar gene in mouse suggest a role in the pathogenesis of Huntington disease. Alternative splicing results in transcript variants encoding distinct isoforms. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
404 residues, UniProt reviewed canonical sequence.
>P29466|CASP1
1 MADKVLKEKR KLFIRSMGEG TINGLLDELL QTRVLNKEEM EKVKRENATV MDKTRALIDS
61 VIPKGAQACQ ICITYICEED SYLAGTLGLS ADQTSGNYLN MQDSQGVLSS FPAPQAVQDN
121 PAMPTSSGSE GNVKLCSLEE AQRIWKQKSA EIYPIMDKSS RTRLALIICN EEFDSIPRRT
181 GAEVDITGMT MLLQNLGYSV DVKKNLTASD MTTELEAFAH RPEHKTSDST FLVFMSHGIR
241 EGICGKKHSE QVPDILQLNA IFNMLNTKNC PSLKDKPKVI IIQACRGDSP GVVWFKDSVG
301 VSGNLSLPTT EEFEDDAIKK AHIEKDFIAF CSSTPDNVSW RHPTMGSVFI GRLIEHMQEY
361 ACSCDVEEIF RKVRFSFEQP DGRAQMPTTE RVTLTRCFYL FPGHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CASP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 122 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 122 nTPM
- duodenum: 121 nTPM
- spleen: 87 nTPM
- appendix: 58 nTPM
- lymph node: 50 nTPM
- rectum: 47 nTPM
Single-cell type
- monocytes: 165 nCPM
- hofbauer cells: 135 nCPM
- neutrophils: 134 nCPM
- kupffer cells: 118 nCPM
- cdc: 113 nCPM
- enterocytes: 95 nCPM
Immune cell
- non-classical monocyte: 377 nTPM
- intermediate monocyte: 355 nTPM
- classical monocyte: 244 nTPM
- neutrophil: 220 nTPM
- total PBMC: 218 nTPM
- myeloid DC: 216 nTPM
Brain region
- white matter: 10 nTPM
- medulla oblongata: 9.7 nTPM
- cerebral cortex: 9.3 nTPM
- spinal cord: 8.1 nTPM
- pons: 7.5 nTPM
- thalamus: 7.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- AIM2 inflammasome complex assembly
- apoptotic process
- cellular response to lipopolysaccharide
- cellular response to mechanical stimulus
- cellular response to type II interferon
- cytokine precursor processing
- defense response to bacterium
- defense response to virus
- icosanoid biosynthetic process
- osmosensory signaling pathway
- pattern recognition receptor signaling pathway
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of inflammatory response
- positive regulation of interleukin-1 beta production
- positive regulation of interleukin-18 production
- positive regulation of tumor necrosis factor-mediated signaling pathway
- protein autoprocessing
- protein maturation
- proteolysis
- pyroptotic inflammatory response
- regulation of apoptotic process
- regulation of inflammatory response
- signal transduction
- signaling receptor ligand precursor processing
Molecular functions
- CARD domain binding
- cysteine-type endopeptidase activator activity involved in apoptotic process
- cysteine-type endopeptidase activity
- cytokine binding
- endopeptidase activity
- identical protein binding
- kinase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase C14, p20 domain
- CARD domain
- Peptidase C14, caspase non-catalytic subunit p10
- Peptidase C14 family
- Death-like domain superfamily
- Peptidase C14, caspase domain
- Peptidase C14A, caspase catalytic domain
- Peptidase family C14A, His active site
- Caspase-like domain superfamily
- Peptidase family C14A, cysteine active site
- Caspase recruitment domain
- Caspase domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CASP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CASP1 as an antibody target. Whether an autoantibody or antibody against CASP1 could matter depends on whether native CASP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CASP1 is annotated at the cell surface, where native CASP1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CASP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...